Iridium Corporation (IRMD)
NASDAQ · Healthcare
Iridium Corporation Income Statement 2020–2025
| Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | |
|---|---|---|---|---|---|---|
| Revenues | ||||||
| Revenue | 83.8M | 73.2M | 65.6M | 53.3M | 41.8M | 31.7M |
| Gross Profit | 64.3M | 56.3M | 50.2M | 41.3M | 32.0M | 23.6M |
| Profitability | ||||||
| Operating Income | 26.1M | 22.0M | 20.0M | 15.6M | 9.8M | -756,091 |
| EBITDA | 27.1M | 22.8M | 21.0M | 16.3M | 11.2M | 575,705 |
| Net Income | 22.5M | 19.2M | 17.2M | 12.8M | 9.3M | 1.4M |
| Per Share Data | ||||||
| EPS (diluted) | $1.75 | $1.50 | $1.35 | $1.02 | $0.74 | $0.11 |
| Shares Outstanding (dil.) | 13M | 13M | 13M | 13M | 12M | 12M |
Iridium Corporation Income Statement — FAQ
Iridium Corporation (IRMD) income statement over the last 6 years — annual and quarterly figures with year-over-year growth and charts.
Where can I see IRMD's income statement history?
The chart and table above show Iridium Corporation's income statement by year and by quarter, including the growth rate.